Patent · US Expired

Methods and compositions for reducing ischemic injury of the heart by administering adenosine receptor agonists and antagonists

US6586413B2 · kind B2 · utility

36Cited by
2References
73Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMar 5, 2001
Grant dateJul 1, 2003
Priority date
Expiry dateMar 5, 2021

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K47/55
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compositions and methods for reducing or preventing ischemic damage of the heart are disclosed. A preferred embodiment of the invention comprises the simultaneous administration of specific A3/A1 receptor agonists, to patients suffering from ischemic damage or at risk for the same. In yet another embodiment of the invention, a binary conjugate which acts as an agonist for the A3 receptor and an antagonist at the A2a receptor, is administered to reduce or prevent ischemic damage to the heart.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.